Global Transcatheter Aortic Valve Replacement/Implantation Market to reach USD 9.2 billion by 2026

Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market Size study, by Procedure (Transfemoral Implantation, Transapical Implantation, Transaortic Implantation) and by Regional Forecasts 2019-2026
Product Code:  HALMDAE_55150996
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Key Trends
1.3.	Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1.	Transcatheter Aortic Valve Replacement/Implantation Market, by Procedure, 2016-2026 (USD Billion)
1.3.2.	Transcatheter Aortic Valve Replacement/Implantation Market, by Region, 2016-2026 (USD Billion)
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Transcatheter Aortic Valve Replacement/Implantation Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Industry Evolution
2.2.2.	Scope of the Study
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Transcatheter Aortic Valve Replacement/Implantation Market Dynamics	
3.1.	See Saw Analysis
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Transcatheter Aortic Valve Replacement/Implantation Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Buyers
4.1.2.	Bargaining Power of Suppliers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model
4.2.	PEST Analysis
4.2.1.	Political Scenario
4.2.2.	Economic Scenario
4.2.3.	Social Scenario
4.2.4.	Technological Scenario
4.3.	Key Buying Criteria (On Demand)
4.4.	Regulatory Framework (On Demand)
4.5.	Investment Vs Adoption Scenario (On Demand)
4.6.	Analyst Recommendation & Conclusion
Chapter 5.	Global Transcatheter Aortic Valve Replacement/Implantation Market, by Procedure 
5.1.	Market Snapshot 
5.2.	Market Performance - Potential Model
5.3.	Transcatheter Aortic Valve Replacement/Implantation Market, Sub Segment Analysis
5.3.1.	  Transfemoral Implantation    
5.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.	 Transapical Implantation
5.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.3.	  Transaortic Implantation
5.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6.	Global Transcatheter Aortic Valve Replacement/Implantation Market, by Regional Analysis
6.1.	Transcatheter Aortic Valve Replacement/Implantation Market, Regional Market Snapshot (2016-2026)
6.2.	North America Transcatheter Aortic Valve Replacement/Implantation Market Snapshot
6.2.1.	U.S.
6.2.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.2.1.2.	 Procedure breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.2.2.	Canada
6.2.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.2.2.2.	Procedure breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.3.	Europe Transcatheter Aortic Valve Replacement/Implantation Market Snapshot
6.3.1.	U.K. 
6.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2.	Procedure breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.3.2.	Germany
6.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2.	Procedure breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.3.3.	Rest of Europe
6.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.2.	Procedure breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.4.	Asia Transcatheter Aortic Valve Replacement/Implantation Market Snapshot
6.4.1.	China 
6.4.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.1.2.	Procedure breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.4.2.	India 
6.4.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.2.2.	Procedure breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.4.3.	Japan
6.4.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.3.2.	Procedure breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.4.4.	Rest of Asia Pacific
6.4.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.4.2.	Procedure breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.5.	Latin America Transcatheter Aortic Valve Replacement/Implantation Market Snapshot
6.5.1.	Brazil 
6.5.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.5.1.2.	Procedure breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.5.2.	Mexico 
6.5.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.5.2.2.	Procedure breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.6.	Rest of The World 
6.6.1.	Middle East and Africa
6.6.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.6.1.2.	Procedure breakdown estimates & forecasts, 2016-2026 (USD Billion) 
Chapter 7.	Competitive Intelligence
7.1.	Company Market Share (Subject to Data Availability)
7.2.	Top Market Strategies
7.3.	Company Profiles
7.3.1.	  Medtronic plc
7.3.1.1.	Overview
7.3.1.2.	Financial (Subject to Data Availability)
7.3.1.3.	Product Summary
7.3.1.4.	Recent Developments
7.3.2.	  Boston Scientific Corporation
7.3.3.	Meril Life Sciences Pvt. Ltd. Inc.
7.3.4.	Edwards Lifesciences Corporation
7.3.5.	St. Jude Medical Inc.
7.3.6.	JenaValve Technology Inc.
7.3.7.	Bracco SpA
7.3.8.	Transcatheter Technologies GmbH
7.3.9.	Abbott
Chapter 8.	Research Process
8.1.	Research Process
8.1.1.	Data Mining
8.1.2.	Analysis
8.1.3.	Market Estimation
8.1.4.	Validation
8.1.5.	Publishing
8.1.6.	Research Assumption

Global Transcatheter Aortic Valve Replacement/Implantation Market is valued approximately USD 3 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 13.5 % over the forecast period 2019-2026. Technological enhancements in transcatheter aortic valve replacement procedure and Increasing number of patients suffering from various heart diseases such as artery diseases and heart failures are the main factors in the growth of Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market. Besides this, there are some risks associated with TAVR like valve leakage problem in which Sometimes blood leaks around the new valve because of improper replacement, the risk of vessel damage and high cost associated with TAVR are the factors that hinder the growth of Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market. TAVR/TAVI is a process of replacing the heart’s aortic valve through blood vessels. Cardiovascular diseases arise due to improper functioning of aortic valves, which in turn need to replace the valve with a suitable procedure. In transcatheter aortic valve replacement process, a transcatheter heart valve is used for valvular heart disease patients who possess high risk associated with open-heart surgery and there may be life-threatening risks to the patient. With the technological development, the research in the TAVR sector is increasing rapidly, along with growing adoption of advanced devices & procedural methods and new innovations are leading to the adoption of transcatheter aortic valve replacement procedure. However, TAVR devices are considered to be cost-effective in the case of high-risk patients and the TAVR method has reduced the patient recovery, reducing overall expenditure and therefore making a significant growth in the market.

The regional analysis of Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share. Whereas, owing to the countries such as China, Japan, and India, Asia Pacific region is anticipated to exhibit higher growth rate / CAGR over the forecast period 2019-2026.
Major market player included in this report are:
Medtronic plc
Boston Scientific Corporation
Meril Life Sciences Pvt. Ltd. Inc.
Edwards Lifesciences Corporation
St. Jude Medical Inc.
JenaValve Technology Inc.
Bracco SpA
Transcatheter Technologies GmbH
Abbott
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Procedure:
Transfemoral Implantation
Transapical Implantation
Transaortic Implantation

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Transcatheter Aortic Valve Replacement/Implantation Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…